Diltiazem potentiates the negative inotropic action of nimodipine in heart.
In Langendorff perfused rat hearts, nimodipine enhances coronary flow and inhibits contractility. The binding of [3H]nimodipine (160 Ci/mmol) to sarcolemma isolated from dog heart revealed a KD of 0.2 nM. d-cis-Diltiazem, but not 1-cis-diltiazem, a less active stereoisomer, stimulated [3H]nimodipine (0.17 nM) binding to sarcolemmal membranes (ED50 for diltiazem = 1.1 microM). In the presence of 10 microM d-cis-diltiazem, [3H]nimodipine binding sites were doubled, but there was no change in the apparent affinity. Perfused rat hearts were treated with 250 nM d-cis-diltiazem. The negative inotropic response to nimodipine was dramatically potentiated (I50, from 1.1 to 0.033 microM). The pharmacological and binding effects were observed only at 37 degrees C. It is possible that diltiazem in some way converts low affinity to high affinity sites.
D000818:Animals; D001552:Benzazepines / Q000494:pharmacology*; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D004110:Diltiazem / Q000494:pharmacology*; D004285:Dogs; D004357:Drug Synergism; D006321:Heart / Q000187:drug effects*; D007700:Kinetics; D009200:Myocardial Contraction / Q000187:drug effects*; D009539:Nicotinic Acids / Q000494:pharmacology*; D009553:Nimodipine; D051381:Rats; D012508:Sarcolemma / Q000187:drug effects; D013237:Stereoisomerism
D001552:Benzazepines; D002121:Calcium Channel Blockers; D009539:Nicotinic Acids; D009553:Nimodipine; D004110:Diltiazem